期刊文献+

K-ras基因突变和p21蛋白的表达与子宫内膜异位症恶性转化的关系 被引量:1

The association of K-ras mutations and p21 expressions with malignant transformation of endometriosis
下载PDF
导出
摘要 目的:探讨K-ras基因点突变和p21蛋白的表达与子宫内膜异位症(内异症)恶性转化的关系。方法:应用PCR-RFLP和免疫组织化学技术,对与内异症相关的3例卵巢子宫内膜样癌及3例卵巢透明细胞癌中K-ras基因第一外显子第12、13密码子的突变情况以及p21蛋白的表达进行研究,并将结果与和内异症不相关的卵巢子宫内膜样癌、卵巢透明细胞癌以及不典型内异症、卵巢内异症相比较。结果:起源于内异症的卵巢子宫内膜样癌和卵巢透明细胞癌中各有1例检测到K-ras基因第12密码子发生突变,突变类型为GGT→TGT,即甘氨酸→半胱氨酸,其余标本均未见第12、13密码子突变。p21蛋白在与内异症相关的卵巢肿瘤中的表达高于其他各组(P<0.05)。结论:K-ras基因的改变与内异症恶性转化可能具有某种联系。p21蛋白在与内异症相关的卵巢癌中表达较高,说明它们的发病可能涉及不同的分子机制。 Objective To explore the association of K-ras mutations and p21 expressions with malignant transformation of endometriosis.Methods K-ras mutations in codons 12 and 13 and expressions of p21 protein were detected in 3 endometriosis-related ovarian endometrioid carcinomas and in 3 endometriosis-related ovarian clear cell carcinomas using PCR-RFLP and immunohisochemical technique.The findings were compared with those from ovarian carcinomas unrelated to endometriosis, atypical endometriosis, and ovarian endome...
出处 《实用医学杂志》 CAS 北大核心 2009年第5期712-714,共3页 The Journal of Practical Medicine
基金 山东省科技攻关计划基金资助项目(编号:006GG2202027)
关键词 子宫内膜异位症 恶性转化 K-RAS基因 P21 Endometriosis Malignant transformation K-ras p21
  • 相关文献

参考文献1

二级参考文献8

  • 1Bos J L. Ras oncogenes in human cancer: a review [ J ]. Cancer Research, 1989,49:4682-4469.
  • 2Halatsch M E, Hitch K I,Weinel R J,et al. Differential activation of the c-k-ras-2 proto-oncogene in human colorectal carcinoma[ J ]. Anti-cancer Research, 1998,18:2323-2325.
  • 3Doolittle B R,Emannel J,Tuttle C ,et al. Detection of the mutated k-ras biomarker in colorectal carcinoma[ J]. Exp Mol Pathol,2001,70: 289-301.
  • 4Breivik J, Neling G I, Spurkland A, et al. K-ras mutation in colorectal cancer:relations to patient age, sex and tumor location [ J ]. Br J Cancer, 1994,69:367-371.
  • 5Tang W Y, Elnatan J, Lee Y S, et al. c-K-ras mutation in colorectal adenocarcinomas from a country with a rapidly changing colorectal cancer incidence[J]. Br J Cancer, 1999,81:237-241.
  • 6Suzuki T, Ishioka C, Gamo M, et al. Genetic alterations of human colorectal cancer[ J]. Gan To Kagaku Ryoho, 1994,21:343-350.
  • 7Chiang J W,Wu Y H,Chou T B,et al. K-ras codon 12 mutation determines the polypoid growth of colorectal cancer[J]. Cancer Res, 1998,58:3289-3293.
  • 8Finkelstein S D, Sayegh R, Christensen S, et al. Genetype ciassification of colorectal adenocarcinoma biologic behavior correlates with K- ras-2 mutation type[ J]. Cancer, 1993,71:3827-3838.

同被引文献9

  • 1Stites E C,Ravichandran K S.A systems perspective of ras signaling in cancer[J].Clin Cancer Res,2009,15(5):1510-1513.
  • 2Karnoub A E,Weinberg R A.Ras oncogenes:split personalities[J].Nat Rev Mol Cell Biol,2008,9(7):517-531.
  • 3Diaz-Flores E,Shannon K.Targeting oncogenic Ras[J].Genes Dev,2007,21(16):1989-1992.
  • 4Yu S H,Wang T H,Au L C.Specific repression of mutant K-RAS by 10.23 DNAzyme:Sensitizing cancer cell to anti-cancer therapies[J].Bioch Bioph Res Communi-cat,2009,378(2):230-234.
  • 5Shields D J,Murphy E A,Desgrosellier J S,et al.Oncogenic Ras/Src cooperativity in pancreatic neoplasia[J].Oncogene,2011,30(18):2123-2134.
  • 6Boukamp P.Non-melanoma skin cancer:what drives tumor development and progression?[J].Carcinogenesis,2005,26(10):1657-1667.
  • 7Milagre C,Dhomen N,Geyer F c,et al.A mouse model of melanoma driven by oncogenic KRAS[J].Cancer Res,2010,70(13):5549-5557.
  • 8Nindl I,Gottsehling M,Krawtchenko N,et al.Low prevalence of p53,p16 (INK4a) and Ha-ras tumour-specific mutations inlow-graded actinic keratosis[J].Br J Dermatol,2007,156(suppl 3):34-39.
  • 9Zaravinos A,Kanellou P,Spandidos D A.Viral DNA detection and RAS mutations in actinic keratosis and nonmelanoma skin cancers[J].Br J Dermatol,2010,162(2):325-231.

引证文献1

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部